Public sector focus Karna primarily serves government clients such as the CDC, indicating strong alignment with public health and government procurement cycles. Solutions and services that address health science, research, communications, and technology within federal and state agencies may resonate, suggesting sales opportunities around health communications campaigns, data analysis, and tech-enabled health initiatives.
Health tech capabilities The company emphasizes transformational strategies, evidence-based approaches, and effective technologies, supported by a tech stack including data analysis tools (IBM SPSS), development frameworks (Backbone.js, Java), and cybersecurity (NIST Cybersecurity Framework). This points to opportunities selling analytics, data visualization, and secure health information systems to clients needing rigorous evidence-based results.
Recent health campaigns Recent activity includes immunization coalition toolkit development, formative research for toolkit creation, and training initiatives for OB-GYNs on vaccine conversations. Sales opportunities exist in expanding toolkit offerings, workforce training, and communication campaigns for immunization programs or public health education with government and healthcare partners.
Convergence partnerships Historical partnerships with organizations like ACOG, CDC, Brunet-Garcia, and The Foam People suggest a capability to collaborate across agencies, advertisers, and healthcare associations. Business development can target joint proposals, expanded public health campaign work, and financing-friendly customer journeys leveraging partner networks.
Growth potential With a revenue range of 100M-250M and a mid-sized employee base, Karna sits in a scalable services position to expand into larger health science and technology service contracts, as well as broader federal procurement opportunities. Target opportunities could include expanding into higher-volume health communications programs and data-driven health initiatives across government clients.